CLS board appoints Dan Mogren as acting CEO when Lars-Erik Eriksson resigns at his own request
Clinical Laserthermia System AB (publ) (CLS) announces the board’s decision to appoint Dan Mogren as acting CEO for the company, as Lars-Erik Eriksson, who has been the company’s CEO from its start in 2006, leaves his assignment at his own request. Dan Mogren has been Chief Commercial Officer in CLS since 2014 and, among other things, responsible for the company’s U.S. operations. Lars-Erik Eriksson will continue to be part of CLS’ executive management as Chief Financial Officer. – First of all I’d like direct my warmest thanks to Lars-Erik for his work as CEO of CLS. He has meant a lot